Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study have?
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study has 40 citations in the OpenAlex counts ScholarIQ stores.
When was Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study published?
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study has 2019 year in the ScholarIQ index.
What is the open-access status of Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study?
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study has closed oa status in the ScholarIQ index.
What is the DOI of Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study?
The DOI for Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study is on the source record.
What is the PMID of Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study?
The PMID for Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study is on the source record.
What is the OpenAlex record for Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study?
The OpenAlex for Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study is on the source record.